Oncobit
PrivateLast Round
Early Funding
Nov 27, 2025
Total Funding Raised
$6.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oncobit operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was an Early Funding round in November 2025.
Oncobit AG is a medtech company that has developed a scalable, data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers in liquid biopsies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncobit Comparables
Compare Oncobit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hedera Dx | 85% | |
| OncoDNA | 83% | |
| Adela | 80% |
For institutional investors. Book with your work email.
Oncobit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 27, 2025 | ||||
| Early Funding | Nov 20, 2024 | ||||
| Seed | Apr 29, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncobit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avanteca Partners | Seed |
| ID SOLUTIONS | Early Funding |
| GF Group Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles increased to 5, 36% of headcount.
- Aug 21, 2026
Monthly visitors grew 104% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Oncobit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncobit's valuation, stock price, and market status.
Is Oncobit a public or private company?
Oncobit is a private company.
What is the current stock price of Oncobit?
Oncobit is a private company, so its shares have no public market price. Caplight tracks Oncobit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncobit worth (valuation)?
Valuation information for Oncobit is not publicly available.
Can I buy Oncobit stock?
Oncobit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncobit's last funding round?
Oncobit's most recent funding round was Early Funding on November 27, 2025.
Who are the main investors in Oncobit?
Key investors in Oncobit include Avanteca Partners, ID SOLUTIONS, GF Group Holding.
Will Oncobit IPO soon?
No public IPO plans have been announced for Oncobit.
How can I track Oncobit secondary market activity?
Caplight tracks bids, offers, and trades in Oncobit's shares on secondary markets.